Advances in Immunotherapy for Transplant Oncology-Reference-Cited by-同舟云学术

Advances in Immunotherapy for Transplant Oncology

Published:2024-06-28 Issue:13 Volume:16 Page:2369
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Abdelrahim Maen¹,Esmail Abdullah¹^ORCID,He Aiwu Ruth²,Khushman Moh’d³^ORCID,Rayyan Yaser⁴^ORCID

Affiliation:

1. Section of GI Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA

2. Gastrointestinal Medical Oncology, Georgetown University Hospital, Washington, DC 20007, USA

3. Division of Oncology, Washington University, St. Louis, MO 63110, USA

4. Department of Gastroenterology & Hepatology, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan

Abstract

The increasing incidence of global cancer rates has created an entirely new demand for curative treatment modalities to improve patient outcomes [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/13/2369/pdf

Reference26 articles.

1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2021

2. Cholangiocarcinoma and liver transplantation: What we know so far?;Safarpour;World J. Gastrointest. Pathophysiol.,2021

3. Abboud, K., Umoru, G., Esmail, A., Abudayyeh, A., Murakami, N., Al-Shamsi, H.O., Javle, M., Saharia, A., Connor, A.A., and Kodali, S. (2023). Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers, 15.

4. Zhang, Y., Esmail, A., Mazzaferro, V., and Abdelrahim, M. (2022). Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision. Cancers, 14.

5. Update on the Management of Cholangiocarcinoma;Skipworth;Dig. Dis.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal Update on Immunotherapy and Liver Transplantation in the Era of Transplant Oncology;Current Oncology;2024-08-28

2. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08